Optigenex Inc. and Its Exclusive Licensee, Ceregenex Inc. Report Strong Direct to Consumer Market Acceptance of Activar(R) With AC-11(R) Skin Care Products and AIO Premium Cellular Health(TM) With AC-11(R)

NEW YORK, NY--(Marketwire - December 17, 2010) -

Highlighted Links

MacReport Media Publishing

Optigenex Inc. (PINKSHEETS: OPGX) announced today that its manufacturing, distribution and sales partner, Ceregenex Inc. (formerly known as Ceres Living) reports strong sales nationwide following a much anticipated national sales roll-out of Activar® brand of next generation topical cosmeceuticals with AC-11® and the advanced dietary supplement AIO Premium Cellular Health™ with AC-11®.

At national sales conferences held in October at Atlanta, Georgia and in late November at Anaheim, California, Ceregenex introduced its Direct to Consumer business affiliates to the proprietary line of Activar® and AIO Premium Cellular Health™ products that feature AC-11®. Speakers headlining the Atlanta conference featured a number of highly recognized leaders in the fields of dermatology, anti-aging and stem cell medical research, including Dr. Robin L. Smith, Dr. Ron Rothenberg and Dr. Noah Scheinfeld.

AC-11® is a patented, all natural ingredient developed by Optigenex that works both topically and orally to help the body's natural ability to repair damaged DNA as a result of overexposure to the sun and other internal and external stressors.

Daniel Zwiren, president and CEO of Optigenex, said, "We are excited by the enthusiastic reception Ceregenex reports that Activar® and AIO™ products have received from Ceregenex's network of Direct to Consumer sales professionals and accordingly we expect vigorous sales in 2011, plus increased exposure as these products are later introduced internationally."

Richard Anzalone, president & CEO of Ceregenex Inc., added, "Our business affiliates have achieved significant and meaningful growth through the sales of Activar® and AIO™. We feel that we have a distinct competitive advantage due to the positive experience our customers and affiliates are reporting. We believe that the benefits of our relationship with Optigenex to our affiliates and consumers will continue to grow for the foreseeable future."

About Optigenex Inc.:
Optigenex Inc. is a technology-based developer of proprietary healthy-aging products for various wellness-related industries, including, beauty, dietary supplements and personal care products. AC-11® (formerly known as C-MED-100®) is the company's patented all-natural extract from the medicinal herb Uncaria tomentosa. From its origins in the Amazon Rain Forest, AC-11® delivers unique bioactive compounds of water soluble carboxy alkyl esters (CAEs™) that form the backbone of the company's revolutionary approach to DNA care and healthy aging. For more information about Optigenex please visit our website: www.optigenex.com

About Ceregenex Inc.:

Ceregenex Inc. ("Ceregenex") is a California-based health care-related products and services company that develops, manufactures and distributes advanced personal care and wellness products. The Company has a long term exclusive license agreement with Optigenex for marketing and distribution of branded cosmeceutical and dietary supplement products containing AC-11®, including AIO Premium Cellular Health™ with AC-11® and the ACTIVAR® family of skin care products with AC-11®. For more information about Ceregenex Inc., please contact the company at (818) 998 4769 or visit our website at www.Ceregenex.com.

Safe Harbor Statement
The statements made in this press release have not been evaluated by the Food and Drug Administration (FDA). The products mentioned herein are not intended to treat, diagnose, cure or prevent any disease. This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that represent the company's current expectations and beliefs. The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. The forward-looking statements set forth the company's beliefs as of the date of this release, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.